Dyax

 

Advancing Novel Biotherapeutics Since 1995®

Press Releases

All Releases
View Summary Dyax Corp. to Host First Quarter 2014 Earnings Call and Webcast
Apr 17, 2014
PDF 17.1 KB Add to Briefcase
View Summary Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Apr 16, 2014
PDF 20.3 KB Add to Briefcase
View Summary Dyax Receives FDA Approval to Expand Use of KALBITOR® (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema to Patients 12 Years of Age and Older
Apr 3, 2014
PDF 21.2 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 13th Annual Needham Healthcare Conference
Apr 2, 2014
PDF 20.9 KB Add to Briefcase
View Summary Dyax Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Mar 25, 2014
PDF 20.4 KB Add to Briefcase
View Summary Dyax Announces Pricing of $74 Million Public Offering of Common Stock
Mar 14, 2014
PDF 20.4 KB Add to Briefcase
View Summary Dyax Announces Proposed Public Offering of Common Stock
Mar 13, 2014
PDF 19.8 KB Add to Briefcase
View Summary Dyax Corp. Announces Fourth Quarter and Full Year 2013 Financial Results
Feb 28, 2014
PDF 32.5 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 2014 Cowen and Company 34th Annual Health Care Conference
Feb 26, 2014
PDF 20.3 KB Add to Briefcase
View Summary Dyax Announces Positive Results from Phase 1a Clinical Trial of DX-2930
Feb 25, 2014
PDF 24.4 KB Add to Briefcase
View Summary Dyax Corp. to Host Fourth Quarter and Year End 2013 Earnings Call and Webcast
Feb 13, 2014
PDF 17.1 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 2014 Leerink Global Healthcare Conference
Feb 7, 2014
PDF 16.6 KB Add to Briefcase
View Summary Dyax Presents Investigational DX-2930 and Biomarker Assay Data at the 2013 American Society of Hematology Annual Meeting
Dec 9, 2013
PDF 25.2 KB Add to Briefcase
View Summary Dyax Receives Orphan Drug Designation from the U.S. FDA for DX-2930 in Hereditary Angioedema
Dec 5, 2013
PDF 20.5 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 2013 Deutsche Bank BioFEST Conference
Nov 26, 2013
PDF 20.7 KB Add to Briefcase
View Summary Dyax Corp. Announces Five HAE Allies℠ Honorees, Underscoring Critical Role of Support for Patients with Hereditary Angioedema
Nov 21, 2013
PDF 116.4 KB Add to Briefcase
View Summary Dyax Corp. Announces Third Quarter 2013 Financial Results
Oct 22, 2013
PDF 34.8 KB Add to Briefcase
View Summary Dyax Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Oct 18, 2013
PDF 20.0 KB Add to Briefcase
View Summary Dyax Corp. to Host Third Quarter 2013 Earnings Call and Webcast
Oct 15, 2013
PDF 21.3 KB Add to Briefcase
View Summary Dyax Announces Pricing of $60 Million Public Offering of Common Stock
Oct 9, 2013
PDF 20.1 KB Add to Briefcase
Showing 1-20 of 191 Page: 1 2 3 4 5 ... 10  Next 20
Add to Briefcase = add release to Briefcase
 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?